NCT03610165

Brief Summary

Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension. Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
214

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 12, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 13, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

February 5, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

May 19, 2021

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

July 13, 2018

Results QC Date

December 15, 2020

Last Update Submit

April 27, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Time- Weighted Average (TWA) MAP Under a Threshold of 65 mmHg.

    MAP stands for mean arterial pressure. Time-weighted average MAP below 65 mmHg threshold for each patient was derived by dividing AUC-MAP by the time interval between the first and the last MAP measurements.

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • Hypotension Severity (AUC-MAP) Under a Threshold of 65.

    MAP stands for mean arterial pressure; Calculation of a specific area started when MAP was less than 65 mmHg and ended when MAP was greater than 65 mmHg; Hypotension severity (AUC-MAP) below the threshold of 65 mmHg was calculated as the cumulative sum of the areas below the given threshold for a patient using the trapezoid rule and measured in units of mmHg times minutes.

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery) .

  • Duration of MAP Under a Threshold of 65 mmHg.

    MAP stands for mean arterial pressure; Duration is the total amount of time (in minutes) that the MAP under a threshold of 65 mmHg

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

Secondary Outcomes (6)

  • Time-weighted Average MAP Below a Threshold of 60 mmHg Per Case

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • Time-weighted Average MAP Below a Threshold of 55 mmHg Per Case

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • Hypotension Severity (AUC-MAP) Under a Threshold of 60 mmHg.

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • Hypotension Severity (AUC-MAP) Under a Threshold of 55 mmHg.

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • Duration of MAP Under a Threshold of 60 mmHg.

    MAP measurements were recorded every 20 s by the EV1000 system from induction (start anesthesia) to leaving Operation room (end of surgery).

  • +1 more secondary outcomes

Study Arms (2)

Arterial line - Control

PLACEBO COMPARATOR

Arterial line waveform and pressure

Device: Control

Acumen HPI-enabled EV1000 screen

EXPERIMENTAL

Arterial line waveform and pressure + HPI alert from EV1000 monitor

Device: Acumen HPI-enabled EV1000 screen

Interventions

Acumen HPI-enabled EV1000 screen.

Acumen HPI-enabled EV1000 screen
ControlDEVICE

Arterial waveform and pressures

Arterial line - Control

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • Age ≥45 years
  • ASA Physical Status 3 or 4
  • Moderate- or high-risk surgery (for example, orthopedic, spine, urology, and general surgery)
  • Planned invasive blood pressure monitoring
  • General anesthesia
  • Surgery duration expected to last \>2 hours
  • Planned overnight hospitalization

You may not qualify if:

  • Contraindication to the invasive blood pressure monitoring
  • Pregnancy
  • Emergency surgery
  • Known clinically important intracardiac shunts
  • Known aortic stenosis with valve area ≤ 1.5 cm2
  • Known moderate to severe aortic regurgitation
  • Known moderate to severe mitral regurgitation
  • Known moderate to severe mitral stenosis
  • Patient or surgical procedure type known as an SVV limitation16 (e.g. tidal volume \<8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate (HR/RR) ratio \<3.6)
  • Current persistent atrial fibrillation
  • Congestive heart failure with ejection fraction \<35%
  • Neurosurgery
  • Emergent or cardiovascular surgical procedure
  • Patient who is confirmed to be pregnant
  • Refusal of patient or authorized representative to sign consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (1)

  • Maheshwari K, Shimada T, Fang J, Ince I, Mascha EJ, Turan A, Kurz A, Sessler DI. Hypotension Prediction Index software for management of hypotension during moderate- to high-risk noncardiac surgery: protocol for a randomized trial. Trials. 2019 May 3;20(1):255. doi: 10.1186/s13063-019-3329-0.

Results Point of Contact

Title
Dr. Kamal Maheshwari
Organization
Cleveland Clinic Foundation

Study Officials

  • Kamal Maheshwari, MD, MPH

    The Cleveland Clinic

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 13, 2018

First Posted

August 1, 2018

Study Start

July 12, 2018

Primary Completion

June 1, 2019

Study Completion

March 31, 2021

Last Updated

May 19, 2021

Results First Posted

February 5, 2021

Record last verified: 2021-04

Locations